In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pfizer licenses generics portfolio from Aurobindo Pharma

Executive Summary

Indian generics company Aurobindo Pharma has licensed Pfizer rights to market and commercialize 39 oral generics in the US, with 20 of those to be sold in Europe (11 in France). In addition, Pfizer gets rights to sell 12 sterile injectable antibiotics (penicillin and cephalosporin) in the US and Europe.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies